WebCisplatin is a platinum-based agent whose nephrotoxicity is thought related to the chloride in the cis position. Cisplatin gains entry into tubular cells via uptake by the OCT-2 system on the basolateral membrane of proximal tubular cells. • Cellular apoptosis/necrosis develops due to endoplasmic reticulum-induced stress, mitochondrial injury pathways, … The compound cis-[Pt(NH3)2Cl2] was first described by Italian chemist Michele Peyrone in 1845, and known for a long time as Peyrone's salt. The structure was deduced by Alfred Werner in 1893. In 1965, Barnett Rosenberg, Van Camp et al. of Michigan State University discovered that electrolysis of … See more Cisplatin is a chemotherapy medication used to treat a number of cancers. These include testicular cancer, ovarian cancer, cervical cancer, bladder cancer, head and neck cancer, esophageal cancer, lung cancer See more Cisplatin interferes with DNA replication, which kills the fastest proliferating cells, which in theory are cancerous. Following administration, one chloride ion is slowly displaced by water … See more Syntheses of cisplatin start from potassium tetrachloroplatinate. Several procedures are available. One obstacle is the facile formation of See more Cisplatin is administered intravenously as short-term infusion in normal saline for treatment of solid and haematological malignancies. It is used to treat various types of cancers, … See more Cisplatin has a number of side effects that can limit its use: • Nephrotoxicity (kidney damage) is the primary dose … See more Cisplatin is the square planar coordination complex cis-[Pt(NH3)2Cl2]. The prefix cis indicates the cis isomer in which two similar ligands are in adjacent positions. The systematic chemical name of this molecule is cis–diamminedichloroplatinum, where ammine with two … See more Cisplatin has been studied with Auger therapy to increase the therapeutic effects of cisplatin, without increasing normal tissue toxicities. See more
Cisplatin 9. The Discovery - One Scientist
WebSep 18, 2024 · National Center for Biotechnology Information WebAug 26, 2015 · And so, in 1978, cisplatin was approved by the US Food and Drug Administration for use in cancer patients. This international super-group of … how do they make gyro meat
Cisplatin (Cisplatin Injection): Uses, Dosage, Side Effects ... - RxList
WebApr 12, 2024 · Her family history was notable for breast cancer in her mother, lung cancer in her father, and renal cell carcinoma in her sister. ... The patient was started on gemcitabine, cisplatin, and nanoparticle albumin-bound paclitaxel (nab-paclitaxel). After 3 months of chemotherapy, the patient's AFP increased to 43.8 ng/ml and her CA 19-9 … WebJul 1, 2024 · Cisplatin was discovered in 1845 by Michele Peyrone but its biological property was hidden until 1965 when a biophysicist, Dr. Barnett Rosenberg [9] discovered its inhibiting cell division property. WebNov 21, 2024 · However, cisplatin is also used to fight brain tumors. The actual chemical compound of cisplatin is cis - [Pt (NH3)2Cl2] and was identified by Michele Peyrone in 1845, known at that time as ... how do they make gushers